LONDON, UK / / February 27, 2026 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total issued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results